BRE Team Tours MilliporeSigma Location

Life sciences company educates team about St. Louis City location’s capabilities

Representatives from St. Louis Economic Development Partnership (STL Partnership), World Trade Center St. Louis (WTC) and St. Louis Mosaic Project recently joined other members of the Business Retention and Expansion team in a tour of MilliporeSigma’s Cherokee facility on South Second Street in St. Louis City. The Cherokee facility is mixed-use with life science medication manufacturing and packaging operations, plus science labs.

The event featured presentations by David Nogales, chief information officer of life science at MilliporeSigma, as well as additional leadership at MilliporeSigma, plus Rodney Crim, CEO and president at STL Partnership. The event also included tours of the manufacturing facility and labs.

The 10,000 square foot facility opened in 2015 as a commercial antibody drug conjugates (ADC) facility. In 2018, MilliporeSigma, a company of Merck Group, opened a 6,000 square foot laboratory dedicated to ADC development. The Cherokee facility, which has around 400 employees, expanded in 2021 with plans to bring in additional employees as their market growth continues to expand rapidly.

Other BRE partners that took part in the tour included Greater St. Louis Inc., Ameren Missouri, Missouri Small Business Development Centers, Missouri Department of Economic Development, St. Louis Development Corporation and Spire.

The STL Partnership BRE team works to connect St. Louis companies with government and economic development officials. This ensures business owners, leaders and entrepreneurs will know who to reach out to regarding opportunities or challenges. The BRE team’s mission is to ease access between these partners.

To lean more about how to connect with the BRE team, click here.